DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on September 9, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.



More Latest News

Updated Florida Medical Marijuana Course for MMTC Medical Directors
January 5, 2018

Attention Physicians: If you plan to continue to be a Medical Director for a Florida MMTC, click here for more information. Continue reading


Healthiest Weight Webinar: Tuesday, November 14, 2017 at 10:00a.m.
November 3, 2017

Chronic Disease Prevention: A Public Health Perspective. Please click for details on how to register for this webinar. Continue reading